Accessible biosensing Delta Life Science focuses on affordable label-free, multiplexed biosensing powered by photonic integrated circuits, presenting an opportunity to target budget-conscious academic labs, mid-size research groups, and early-stage pharma teams seeking cost-effective scalable diagnostics tools.

Broad application reach Chips and readout devices are positioned for use across medical research, agriculture, and point-of-care diagnostics, enabling cross-industry upsell potential and partnerships with universities, biotech startups, and contract research organizations.

Spinoff credibility As a TNO spinoff with expertise in integrated photonics, leverage credibility to approach institutions and research centers that value high-sensitivity, real-time biomarker analysis for complex panels and kinetic studies.

Planting the platform Recent funding and a clear platform development focus suggest opportunities to partner with investors, grant programs, and large research labs seeking scalable, label-free technologies to accelerate biomarker panel validation and drug screening.

Growth signals Revenue in the low-to-mid single digits with a modest funding round indicates potential for expansion through strategic collaborations with mid-market laboratory suppliers and distributorships, tapping into the broader life sciences channel to scale reach.